iJOBS Seminar: FDA Drug Approval and Case Study

Event Description

Join us for a presentation by Daniel Gordin, PhD, retired pharmaceutical executive and current regulatory affairs consultant, as he discusses the development pathway of an investigational drug from the bench-top to FDA review, including key considerations during the FDA review process. Dr. Gordin will also present a case study on the Bridging Strategy, which addresses changes in the formulation of an experimental drug during its development.  This seminar will give you invaluable first-hand insight to the pharmaceutical drug development process.

Click here to see slides.